SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

NCT03250962 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: SHR-1210
DRUG: Decitabine

Sponsor

Chinese PLA General Hospital